Top Markets
Coin of the day
Chengdu Easton Biopharmaceuticals Co., Ltd. Chengdu Easton Biopharmaceuticals Co., Ltd.

Chengdu Easton Biopharmaceuticals Co., Ltd.

688513
Pozycja w akcjach #9010
Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise... Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise dedicated to the full spectrum of drug development, encompassing research, development, production, and market distribution of medicinal products. The company offers finished medications tailored for various medical disciplines, including pain management (anesthetics/analgesics), cardiovascular health, oncology, and pediatrics. Beyond ready-to-use drugs, it also manufactures active pharmaceutical ingredients (APIs) for a broader range of therapeutic areas, such as cancer treatment, heart conditions, pain relief, anti-inflammatory uses, gastrointestinal issues, antiemetics, neurological and psychiatric disorders, and urinary system ailments. Established in 2009, the firm is headquartered in Chengdu, China.
Cena akcji
$6.32
Ostatnia synchronizacja: 2026-08-28
Kapitalizacja rynkowa
$1.11B
Zmiana (1 dzień)
-1.63%
Zmiana (1 rok)
-31.28%
Kraj
CN
Handel Chengdu Easton Biopharmaceuticals Co., Ltd. (688513)

Kategoria

Historia stopy dywidendy dla Chengdu Easton Biopharmaceuticals Co., Ltd. (688513)
Stopa dywidendy (TTM) dla Chengdu Easton Biopharmaceuticals Co., Ltd. (symbol akcji: 688513) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Chengdu Easton Biopharmaceuticals Co., Ltd. (688513) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji